Family Medicine Doctors in Bridgewater, MA Accepting Medicare

3 Family Medicine doctors found. Showing 1 - 3

Kateri Mccarthy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 545 Bedford St, Bridgewater, MA 02324 Phone: 508-697-3677    Fax: 508-894-0412

Daniel L Becker, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 545 Bedford St, Bridgewater, MA 02324 Phone: 508-697-3677    Fax: 508-697-9396

Sheera Philosophe, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 545 Bedford St, Bridgewater, MA 02324 Phone: 508-697-3677

News Archive

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announce that they have entered into distribution, license and supply agreements with Mundipharma and its network of independent associated companies granting exclusive rights to anamorelin in Norway, Finland, Sweden, Denmark and Iceland.

Impax initiates litigation against Shire over supply of generic Adderall XR

Impax Laboratories, Inc. today announced that it has initiated litigation against Shire LLC and Shire Laboratories, Inc. ("Shire") in order to resolve recent and recurring supply issues of its authorized generic version of Adderall XR®. The Company is seeking to compel Shire to deliver duly ordered amounts of product under the parties' Settlement Agreement and License and Distribution Agreements.

Understanding stroke: Symptoms and treatment

A stroke is a "brain attack" and occurs when blood supply to the brain is cut off. According to Kenneth A. Levin, M.D., Medical Director, The Valley Hospital Stroke Center, "Most strokes are caused by a blood clot that has built up on the wall of a brain artery or one that has traveled there from another part of the body (an embolic stroke or ischemic stroke).

Aeterna Zentaris presents AEZS-131 data against cancer at AACR meeting

Aeterna Zentaris Inc. today announced that a poster on its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131, was presented at the 102nd annual meeting of the American Association for Cancer Research currently held at the Orange County Convention Center in Orlando, Florida.

Read more Medical News

› Verified 5 days ago